Gene deficiency and pharmacological inhibition of caspase-1 confers resilience to chronic social defeat stress via regulating the stability of surface AMPARs

Molecular Psychiatry

Volumn 23, Issue 3, 2018, Pages 556-568

  Li, M X ^a   Zheng, H L ^a   Luo, Y ^a   He, J G ^a   Wang, W ^a   Han, J ^a   Zhang, L ^a   Wang, X ^a   Ni, L ^a   Zhou, H Y ^a   Hu, Z L ^a,b,c   Wu, P F ^a,b,c   Jin, Y ^a,b   Long, L H ^a,b,c   Zhang, H ^a   Hu, G ^d   Chen, J G ^a,b,c,e   Wang, F ^a,b,c,e  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^e BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CASP1 PROTEIN, MOUSE; GLUTAMATE RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME;

ANIMAL; ANIMAL BEHAVIOR; ANXIETY; C57BL MOUSE; DEPRESSION; DISEASE MODEL; DRUG EFFECT; GENETICS; HIPPOCAMPUS; KNOCKOUT MOUSE; MALE; MENTAL STRESS; METABOLISM; MOOD DISORDER; MOUSE; PSYCHOLOGICAL RESILIENCE; SYNAPTIC TRANSMISSION;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CASPASE 1; DEPRESSION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOOD DISORDERS; RECEPTORS, GLUTAMATE; RESILIENCE, PSYCHOLOGICAL; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 85017517167     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2017.76     Document Type: Article

References (73)

1. Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 2016; 22: 238–249. DOI: 10.1038/nm.4050
2. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008; 455: 894–902. DOI: 10.1038/nature07455
3. McKim DB, Niraula A, Tarr AJ, Wohleb ES, Sheridan JF, Godbout JP. Neuroinflammatory dynamics underlie memory impairments after repeated social defeat. J Neurosci 2016; 36: 2590–2604. DOI: 10.1523/JNEUROSCI.2394-15.2016
4. Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 2015; 72: 268–275. DOI: 10.1001/jamapsychiatry.2014.2427
5. Janelidze S, Mattei D, Westrin A, Traskman-Bendz L, Brundin L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 2011; 25: 335–339. DOI: 10.1016/j.bbi.2010.10.010
6. Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev 2011; 243: 206–214. DOI: 10.1111/j.1600-065X.2011.01044.x
7. Alcocer-Gomez E, de Miguel M, Casas-Barquero N, Nunez-Vasco J, Sanchez-Alcazar JA, Fernandez-Rodriguez A et al. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun 2014; 36: 111–117. DOI: 10.1016/j.bbi.2013.10.017
8. Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J et al. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry 2016; 21: 797–805. DOI: 10.1038/mp.2016.46
9. Lawson MA, McCusker RH, Kelley KW. Interleukin-1 beta converting enzyme is necessary for development of depression-like behavior following intracerebroventricular administration of lipopolysaccharide to mice. J Neuroinflammation 2013; 10: 54.
10. Zhang Y, Liu L, Peng YL, Liu YZ, Wu TY, Shen XL et al. Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors. CNS Neurosci Ther 2014; 20: 119–124. DOI: 10.1111/cns.12170
11. Zhang Y, Liu L, Liu YZ, Shen XL, Wu TY, Zhang T et al. NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation. Int J Neuropsychopharmacol 2015; 18: pii: pyv006. DOI: 10.1093/ijnp/pyv006
12. Cai X, Kallarackal AJ, Kvarta MD, Goluskin S, Gaylor K, Bailey AM et al. Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression. Nat Neurosci 2013; 16: 464–472. DOI: 10.1038/nn.3355
13. Thompson SM, Kallarackal AJ, Kvarta MD, Van Dyke AM, LeGates TA, Cai X. An excitatory synapse hypothesis of depression. Trends Neurosci 2015; 38: 279–294. DOI: 10.1016/j.tins.2015.03.003
14. Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012; 62: 63–77. DOI: 10.1016/j.neuropharm.2011.07.036
15. Maes M, Verkerk R, Vandoolaeghe E, Lin A, Scharpe S. Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiatr Scand 1998; 97: 302–308. DOI: 10.1111/j.1600-0447.1998.tb10004.x
16. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005; 102: 15653–15658. DOI: 10.1073/pnas.0507901102
17. Lim BK, Huang KW, Grueter BA, Rothwell PE, Malenka RC. Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens. Nature 2012; 487: 183–189. DOI: 10.1038/nature11160
18. Yuen EY, Wei J, Liu W, Zhong P, Li X, Yan Z. Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex. Neuron 2012; 73: 962–977. DOI: 10.1016/j.neuron.2011.12.033
19. Gomez-Galan M, De Bundel D, Van Eeckhaut A, Smolders I, Lindskog M. Dysfunctional astrocytic regulation of glutamate transmission in a rat model of depression. Mol Psychiatry 2013; 18: 582–594. DOI: 10.1038/mp.2012.10
20. Maldonado-Irizarry CS, Swanson CJ, Kelley AE. Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J Neurosci 1995; 15: 6779–6788. DOI: 10.1523/JNEUROSCI.15-10-06779.1995
21. Kallarackal AJ, Kvarta MD, Cammarata E, Jaberi L, Cai X, Bailey AM et al. Chronic stress induces a selective decrease in AMPA receptor-mediated synaptic excitation at hippocampal temporoammonic-CA1 synapses. J Neurosci 2013; 33: 15669–15674. DOI: 10.1523/JNEUROSCI.2588-13.2013
22. Akinfiresoye L, Tizabi Y. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR. Psychopharmacology (Berl) 2013; 230: 291–298. DOI: 10.1007/s00213-013-3153-2
23. Chourbaji S, Vogt MA, Fumagalli F, Sohr R, Frasca A, Brandwein C et al. AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression. FASEB J 2008; 22: 3129–3134. DOI: 10.1096/fj.08-106450
24. Vogt MA, Elkin H, Pfeiffer N, Sprengel R, Gass P, Inta D. Impact of adolescent GluA1 AMPA receptor ablation in forebrain excitatory neurons on behavioural correlates of mood disorders. Eur Arch Psychiatry Clin Neurosci 2014; 264: 625–629. DOI: 10.1007/s00406-014-0509-5
25. Lu C, Wang Y, Furukawa K, Fu W, Ouyang X, Mattson MP. Evidence that caspase-1 is a negative regulator of AMPA receptor-mediated long-term potentiation at hippocampal synapses. J Neurochem 2006; 97: 1104–1110. DOI: 10.1111/j.1471-4159.2006.03800.x
26. Bellinger FP, Madamba S, Siggins GR. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 1993; 628: 227–234. DOI: 10.1016/0006-8993(93)90959-Q
27. Lai AY, Swayze RD, El-Husseini A, Song C. Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J Neuroimmunol 2006; 175: 97–106. DOI: 10.1016/j.jneuroim.2006.03.001
28. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 2008; 13: 717–728. DOI: 10.1038/sj.mp.4002055
29. Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V et al. Interleukin-1beta causes anxiety by interacting with the endocannabinoid system. J Neurosci 2012; 32: 13896–13905. DOI: 10.1523/JNEUROSCI.1515-12.2012
30. Patel NA, Romero AA, Zadina JE, Chang SL. Chronic exposure to morphine attenuates expression of interleukin-1 beta in the rat hippocampus. Brain Res 1996; 712: 340–344. DOI: 10.1016/0006-8993(95)01575-2
31. Maeng S, Zarate CA Jr., Du J, Schloesser RJ, McCammon J, Chen G et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 2008; 63: 349–352. DOI: 10.1016/j.biopsych.2007.05.028
32. Reus GZ, Nacif MP, Abelaira HM, Tomaz DB, dos Santos MA, Carlessi AS et al. Ketamine ameliorates depressive-like behaviors and immune alterations in adult rats following maternal deprivation. Neurosci Lett 2015; 584: 83–87. DOI: 10.1016/j.neulet.2014.10.022
33. Liu M, Li J, Dai P, Zhao F, Zheng G, Jing J et al. Microglia activation regulates GluR1 phosphorylation in chronic unpredictable stress-induced cognitive dysfunction. Stress 2015; 18: 96–106. DOI: 10.3109/10253890.2014.995085
34. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995; 80: 401–411. DOI: 10.1016/0092-8674(95)90490-5
35. Golden SA, Covington HE 3rd, Berton O, Russo SJ. A standardized protocol for repeated social defeat stress in mice. Nat Protoc 2011; 6: 1183–1191. DOI: 10.1038/nprot.2011.361
36. Wang W, Sun D, Pan B, Roberts CJ, Sun X, Hillard CJ et al. Deficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress. Neuropsychopharmacology 2010; 35: 2249–2261. DOI: 10.1038/npp.2010.99
37. Mao LM, Wang W, Chu XP, Zhang GC, Liu XY, Yang YJ et al. Stability of surface NMDA receptors controls synaptic and behavioral adaptations to amphetamine. Nat Neurosci 2009; 12: 602–610. DOI: 10.1038/nn.2300
38. Bluthe RM, Dantzer R, Kelley KW. Central mediation of the effects of interleukin-1 on social exploration and body weight in mice. Psychoneuroendocrinology 1997; 22: 1–11. DOI: 10.1016/S0306-4530(96)00042-X
39. Norman GJ, Karelina K, Zhang N, Walton JC, Morris JS, Devries AC. Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury. Mol Psychiatry 2010; 15: 404–414. DOI: 10.1038/mp.2009.91
40. Lu HF, Wu PF, Yang YJ, Xiao W, Fan J, Liu J et al. Interactions between N-ethylmaleimide-sensitive factor and GluR2 in the nucleus accumbens contribute to the expression of locomotor sensitization to cocaine. J Neurosci 2014; 34: 3493–3508. DOI: 10.1523/JNEUROSCI.2594-13.2014
41. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007; 131: 391–404. DOI: 10.1016/j.cell.2007.09.018
42. Feng Z, Liu L, Zhang C, Zheng T, Wang J, Lin M et al. Chronic restraint stress attenuates p53 function and promotes tumorigenesis. Proc Natl Acad Sci USA 2012; 109: 7013–7018. DOI: 10.1073/pnas.1203930109
43. Lee PH, Perlis RH, Jung JY, Byrne EM, Rueckert E, Siburian R et al. Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder. Transl Psychiatry 2012; 2: e184. DOI: 10.1038/tp.2012.95
44. Vollmann-Honsdorf GK, Flugge G, Fuchs E. Chronic psychosocial stress does not affect the number of pyramidal neurons in tree shrew hippocampus. Neurosci Lett 1997; 233: 121–124. DOI: 10.1016/S0304-3940(97)00647-2
45. Tong L, Prieto GA, Kramar EA, Smith ED, Cribbs DH, Lynch G et al. Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1beta via p38 mitogen-activated protein kinase. J Neurosci 2012; 32: 17714–17724. DOI: 10.1523/JNEUROSCI.1253-12.2012
46. Jiang B, Wang F, Yang S, Fang P, Deng ZF, Xiao JL et al. SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway. Int J Neuropsychopharmacol 2014; 18: pii: pyu096.
47. Anacker C, Zunszain PA, Carvalho LA, Pariante CM. The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 2011; 36: 415–425. DOI: 10.1016/j.psyneuen.2010.03.007
48. Koo JW, Duman RS. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA 2008; 105: 751–756. DOI: 10.1073/pnas.0708092105
49. Yao JH, Ye SM, Burgess W, Zachary JF, Kelley KW, Johnson RW. Mice deficient in interleukin-1beta converting enzyme resist anorexia induced by central lipopolysaccharide. Am J Physiol 1999; 277: R1435–R1443.
50. Bilbo SD, Biedenkapp JC, Der-Avakian A, Watkins LR, Rudy JW, Maier SF. Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J Neurosci 2005; 25: 8000–8009. DOI: 10.1523/JNEUROSCI.1748-05.2005
51. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417–426. DOI: 10.1016/S1097-2765(02)00599-3
52. Vigano E, Diamond CE, Spreafico R, Balachander A, Sobota RM, Mortellaro A. Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes. Nat Commun 2015; 6: 8761. DOI: 10.1038/ncomms9761
53. Hu W, Zhang Y, Wu W, Yin Y, Huang D, Wang Y et al. Chronic glucocorticoids exposure enhances neurodegeneration in the frontal cortex and hippocampus via NLRP-1 inflammasome activation in male mice. Brain Behav Immun 2016; 52: 58–70. DOI: 10.1016/j.bbi.2015.09.019
54. Alcocer-Gomez E, Ulecia-Moron C, Marin-Aguilar F, Rybkina T, Casas-Barquero N, Ruiz-Cabello J et al. Stress-induced depressive behaviors require a functional NLRP3 inflammasome. Mol Neurobiol 2016; 53: 4874–4882. DOI: 10.1007/s12035-015-9408-7
55. Iwata M, Ota KT, Li XY, Sakaue F, Li N, Dutheil S et al. Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol Psychiatry 2016; 80: 12–22. DOI: 10.1016/j.biopsych.2015.11.026
56. Momeni M, Ghorban K, Dadmanesh M, Khodadadi H, Bidaki R, Kazemi Arababadi M et al. ASC provides a potential link between depression and inflammatory disorders: a clinical study of depressed Iranian medical students. Nord J Psychiatry 2016; 70: 280–284. DOI: 10.3109/08039488.2015.1100328
57. Koo JW, Duman RS. Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci Lett 2009; 456: 39–43. DOI: 10.1016/j.neulet.2009.03.068
58. Tordera RM, Totterdell S, Wojcik SM, Brose N, Elizalde N, Lasheras B et al. Enhanced anxiety, depressive-like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur J Neurosci 2007; 25: 281–290. DOI: 10.1111/j.1460-9568.2006.05259.x
59. Garcia-Garcia AL, Elizalde N, Matrov D, Harro J, Wojcik SM, Venzala E et al. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1. Biol Psychiatry 2009; 66: 275–282. DOI: 10.1016/j.biopsych.2009.02.027
60. Inta D, Vogt MA, Perreau-Lenz S, Schneider M, Pfeiffer N, Wojcik SM et al. Sensorimotor gating, working and social memory deficits in mice with reduced expression of the vesicular glutamate transporter VGLUT1. Behav Brain Res 2012; 228: 328–332. DOI: 10.1016/j.bbr.2011.12.012
61. Tzanoulinou S, Riccio O, de Boer MW, Sandi C. Peripubertal stress-induced behavioral changes are associated with altered expression of genes involved in excitation and inhibition in the amygdala. Transl Psychiatry 2014; 4: e410. DOI: 10.1038/tp.2014.54
62. Zink M, Vollmayr B, Gebicke-Haerter PJ, Henn FA. Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression. Neuropharmacology 2010; 58: 465–473. DOI: 10.1016/j.neuropharm.2009.09.005
63. Huang GB, Zhao T, Muna SS, Bagalkot TR, Jin HM, Chae HJ et al. Effects of chronic social defeat stress on behaviour, endoplasmic reticulum proteins and choline acetyltransferase in adolescent mice. Int J Neuropsychopharmacol 2013; 16: 1635–1647. DOI: 10.1017/S1461145713000060
64. Matsuo N, Reijmers L, Mayford M. Spine-type-specific recruitment of newly synthesized AMPA receptors with learning. Science 2008; 319: 1104–1107. DOI: 10.1126/science.1149967
65. Hu W, Zhang M, Czeh B, Flugge G, Zhang W. Stress impairs GABAergic network function in the hippocampus by activating nongenomic glucocorticoid receptors and affecting the integrity of the parvalbumin-expressing neuronal network. Neuropsychopharmacology 2010; 35: 1693–1707. DOI: 10.1038/npp.2010.31
66. Filipovic D, Zlatkovic J, Gass P, Inta D. The differential effects of acute vs. chronic stress and their combination on hippocampal parvalbumin and inducible heat shock protein 70 expression. Neuroscience 2013; 236: 47–54. DOI: 10.1016/j.neuroscience.2013.01.033
67. Gemma C, Bachstetter AD, Cole MJ, Fister M, Hudson C, Bickford PC. Blockade of caspase-1 increases neurogenesis in the aged hippocampus. Eur J Neurosci 2007; 26: 2795–2803. DOI: 10.1111/j.1460-9568.2007.05875.x
68. Vereker E, Campbell V, Roche E, McEntee E, Lynch MA. Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J Biol Chem 2000; 275: 26252–26258. DOI: 10.1074/jbc.M002226200
69. Curran BP, Murray HJ, O'Connor JJ. A role for c-Jun N-terminal kinase in the inhibition of long-term potentiation by interleukin-1beta and long-term depression in the rat dentate gyrus in vitro. Neuroscience 2003; 118: 347–357. DOI: 10.1016/S0306-4522(02)00941-7
70. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003; 23: 8692–8700. DOI: 10.1523/JNEUROSCI.23-25-08692.2003
71. Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A et al. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 2013; 493: 674–678. DOI: 10.1038/nature11729
72. Distrutti E, O'Reilly JA, McDonald C, Cipriani S, Renga B, Lynch MA et al. Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. PLoS One 2014; 9: e106503. DOI: 10.1371/journal.pone.0106503
73. Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011; 60: 307–317. DOI: 10.1136/gut.2009.202515